UK markets close in 4 hours 23 minutes

ECO Animal Health Group plc (EAH.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
183.67-1.33 (-0.72%)
As of 10:42AM GMT. Market open.

ECO Animal Health Group plc

78 Coombe Road
New Malden KT3 4QS
United Kingdom
44 20 8336 2900

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees207

Key executives

NameTitlePayExercisedYear born
Mr. Marc Denham Loomes BVSc, MRCVSCEO & Exec. Director540kN/A1961
Mr. Christopher Wilks ACA, BSc, F.C.A.CFO, Fin. Director, Sec. & Director408kN/A1964
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.

Corporate governance

ECO Animal Health Group plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.